linsidomine has been researched along with aspirin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drummer, C; Gerzer, R; Heim, JM; Karrenbrock, B; Niederreiter, B | 1 |
| Basista, M; Grodzińska, L; Swies, J | 1 |
| Gryglewski, RJ; Swies, J | 1 |
| Grünberg, B; Kratzer, MA; Lorenz, R; Negrescu, EV; Siess, W | 1 |
| Järvinen, TA; Järvinen, TL; Moilanen, E; Moilanen, T | 1 |
| Asano, Y; Bucci, E; Koehler, RC; Traystman, RJ; Ulatowski, JA | 1 |
| Gryglewski, RJ; Korbut, R; Starzyk, D | 1 |
| Brunet, A; Devynck, MA; Le Feuvre, C; Le Quan Sang, KH; Metzger, JP; Pham, TD; Vacheron, A | 1 |
| Grosser, N; Schröder, H | 1 |
| Bing, RJ; Yamamoto, T | 1 |
| Brzozowski, T; Konturek, PCh; Konturek, SJ; Kwiecień, S | 1 |
| Angelini, G; Jeremy, JY; Muzaffar, S; Shukla, N | 1 |
| Angelini, GD; Jeremy, JY; Johnson, JL; Shukla, N; Wan, S; Yim, AP | 1 |
| Brzozowski, T; Konturek, PC; Konturek, SJ; Pawlik, MW; Pawlik, WW; S Kwiecien, S; Sliwowski, Z | 1 |
| Chen, W; Jia, Z; Li, J; Li, Y; Misra, HP; Zhou, K; Zhu, H | 1 |
1 review(s) available for linsidomine and aspirin
| Article | Year |
|---|---|
Nitric oxide donors.
Topics: Animals; Aspirin; Drug Tolerance; Heart; Humans; In Vitro Techniques; Molsidomine; Myocardial Infarction; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Superoxides; Triazenes | 2000 |
14 other study(ies) available for linsidomine and aspirin
| Article | Year |
|---|---|
[Platelet aggregation with SIN 1: comparison with isosorbide-5-mononitrate and acetylsalicylic acid].
Topics: Aspirin; Dose-Response Relationship, Drug; Humans; Isosorbide Dinitrate; Molsidomine; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents | 1991 |
The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Aspirin; Cats; Epoprostenol; Female; Fibrinolysis; Humans; In Vitro Techniques; Male; Molsidomine; Oxadiazoles; Platelet Aggregation; Rabbits; Sydnones | 1985 |
Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
Topics: Animals; Arginine; Aspirin; Blood Pressure; Cats; Epoprostenol; Extracorporeal Circulation; Fibrinolysis; Heparitin Sulfate; Iloprost; Infusions, Intravenous; Injections, Intravenous; Molsidomine; Nitric Oxide; Nitroarginine; Platelet Aggregation; Streptokinase; Thrombosis; Vasodilator Agents | 1995 |
Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Topics: Adenosine Triphosphate; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Drug Interactions; Humans; Iloprost; In Vitro Techniques; Iodine Radioisotopes; Molsidomine; Nitric Oxide; Nitroprusside; Phosphorylation; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors | 1995 |
Endogenous nitric oxide and prostaglandin E2 do not regulate the synthesis of each other in interleukin-1 beta-stimulated rat articular cartilage.
Topics: Animals; Aspirin; Cartilage, Articular; Dexamethasone; Dinoprostone; Electron Transport Complex IV; Interleukin-1; Ketoprofen; Kinetics; Male; Molsidomine; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Organ Culture Techniques; Ornithine; Prostaglandin Antagonists; Rats; Rats, Wistar; Triazoles | 1996 |
Effect of cross-linked hemoglobin transfusion on endothelial-dependent dilation in cat pial arterioles.
Topics: Acetylcholine; Animals; Arterioles; Aspirin; Cats; Cross-Linking Reagents; Decanoic Acids; Endothelium, Vascular; Hemoglobins; Humans; Male; Molsidomine; Nitric Oxide Donors; Nitroarginine; Perfusion; Pia Mater; Salicylates; Serum Albumin; Vasodilation | 1998 |
Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro.
Topics: Animals; Aspirin; Drug Interactions; Enzyme Inhibitors; Epoprostenol; Erythrocyte Aggregation; Erythrocyte Deformability; Iloprost; In Vitro Techniques; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Aggregation Inhibitors; Rats; Rats, Wistar | 1999 |
Influence of SIN-1 on platelet Ca2+ handling in patients with suspected coronary artery disease: ex vivo and in vitro studies.
Topics: Angina Pectoris; Aspirin; Biological Transport; Blood Platelets; Calcium; Calcium Signaling; Catalase; Coronary Angiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Molsidomine; Nitric Oxide Donors; Platelet Aggregation Inhibitors; Superoxide Dismutase; Superoxides; Thapsigargin; Thrombin | 2000 |
A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate.
Topics: Animals; Aspirin; Cell Line; Cyclic GMP; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Imidazoles; Kidney; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Protein Binding; Swine | 2000 |
The role of reactive oxygen species in action of nitric oxide-donors on stress-induced gastric mucosal lesions.
Topics: Aldehydes; Animals; Aspirin; Gastric Mucosa; Lipid Peroxidation; Male; Malondialdehyde; Molsidomine; Nitric Oxide Donors; Nitroglycerin; Rats; Rats, Wistar; Reactive Oxygen Species; Regional Blood Flow; S-Nitroso-N-Acetylpenicillamine; Statistics, Nonparametric; Stomach Ulcer; Stress, Psychological; Superoxide Dismutase | 2002 |
Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Evaluation, Preclinical; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Epoprostenol; Glycoproteins; Guanylate Cyclase; Interleukin-1; Lipopolysaccharides; Male; Molsidomine; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; Onium Compounds; Pulmonary Artery; Respiratory Distress Syndrome; Superoxides; Sus scrofa; Tumor Necrosis Factor-alpha | 2004 |
Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
Topics: Administration, Oral; Analysis of Variance; Anastomosis, Surgical; Animals; Aspirin; Carotid Arteries; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Male; Molsidomine; Nitric Oxide Donors; Saphenous Vein; Statistics, Nonparametric; Swine; Tunica Intima | 2007 |
Nitric oxide (NO)-releasing aspirin and (NO) donors in protection of gastric mucosa against stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Mucosa; Immersion; Lipid Peroxidation; Male; Malondialdehyde; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Rats; Rats, Wistar; Reactive Oxygen Species; Regional Blood Flow; Restraint, Physical; S-Nitroso-N-Acetylpenicillamine; Stomach Ulcer; Stress, Psychological; Superoxide Dismutase | 2008 |
Inhibition of peroxynitrite-mediated DNA strand cleavage and hydroxyl radical formation by aspirin at pharmacologically relevant concentrations: implications for cancer intervention.
Topics: Anticarcinogenic Agents; Aspirin; Bacteriophage phi X 174; DNA Cleavage; Humans; Hydroxyl Radical; Molsidomine; Neoplasms; Peroxynitrous Acid; Plasmids | 2009 |